Weijun Wang

Years Active: 2019-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Mengting Ou, Hee-Yeon Cho, Jie Fu, Thu Zan Thein, Weijun Wang, Stephen D Swenson, Radu O Minea, Apostolos Stathopoulos, Axel H Schönthal, Florence M Hofman, Liling Tang, Thomas C Chen
Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate. Autophagy (2023)
Weijun Wang, Haiping He, Nagore I Marín-Ramos, Shan Zeng, Steven D Swenson, Hee-Yeon Cho, Jie Fu, Paul M Beringer, Josh Neman, Ligang Chen, Axel H Schönthal, Thomas C Chen
Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer. Neuro-oncology 23 (10) (2021)
Hee-Yeon Cho, Steve Swenson, Thu Zan Thein, Weijun Wang, Neloni R Wijeratne, Nagore I Marín-Ramos, Jonathan E Katz, Florence M Hofman, Axel H Schönthal, Thomas C Chen
Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice. Neuro-oncology advances 2 (1) (2020)
Hee-Yeon Cho, Thu Zan Thein, Weijun Wang, Stephen D Swenson, Rochelle A Fayngor, Mengting Ou, Nagore I Marín-Ramos, Axel H Schönthal, Florence M Hofman, Thomas C Chen
The Rolipram-Perillyl Alcohol Conjugate (NEO214) Is A Mediator of Cell Death through the Death Receptor Pathway. Molecular cancer therapeutics 18 (3) (2019)

Weijun Wang.css-eqlu8i{font-size:small;padding-left:4px;}